⚠️ This site is in early development. Content is expanding — always consult a CAME for official guidance.
Medications
Important Notice
This page provides general guidance only. Aviation medical decisions are made on a case-by-case basis by Transport Canada and a CAME.
Taking Medications as a Pilot
Medications are assessed according to Transport Canada Civil Aviation Medicine guidance (SI 404-005). Both the underlying condition and effects of the medication are considered for flight safety.
High-Risk Medications
These medications are generally not compatible with aviation safety. CAMEs may not renew a pilot on these medications unless previously approved and stable. If stopped, a washout period is required (typically ≥5 half-lives, may vary by drug).
- Alpha blockers (except BPH treatments)
- Anticholinergics (Scopolamine, Tolterodine, Oxybutynin)
- Antidepressants (most sedating; SSRI/SNRI may require approval)
- Antihistamines with sedating effects (Diphenhydramine, Dimenhydrinate)
- Anti-seizure, Antipsychotics, Anti-Parkinsonian meds
- Benzodiazepines, Sedatives (Zopiclone, Zolpidem)
- Opioids, Cannabis, Psychostimulants/ADHD medications
- Cancer chemotherapy/Immunomodulators
- Mood stabilizers, Muscle relaxants, Cardiac nitrates
- Systemic steroids, any medication warning against driving/flying
Rule of thumb: If you take any of these medications, consult a CAME before flying. Special protocols may exist in rare cases.
Low-Risk Medications
These are typically compatible with aviation if the underlying condition is stable, the medication is tolerated, and ground testing shows no impairment:
- Non-opioid analgesics (Acetaminophen, NSAIDs)
- Non-sedating antihistamines (Loratadine, Cetirizine, Fexofenadine)
- Antacids, proton pump inhibitors, antidiarrheals
- Antibiotics (most; consult RAMO for exceptions)
- Asthma medications if controlled (SABA/LABA, ICS)
- Hormone therapies (Estrogen, Androgen, Contraceptives)
- ED medications (Sildenafil, Vardenafil if no adverse effects)
- Lipid-lowering medications (statins, etc.)
- Nicotine replacement therapy
- Topical treatments and vitamin/mineral supplements
Even low-risk medications require CAME documentation of stability, dose, and absence of side effects.